A detailed history of Ameritas Advisory Services, LLC transactions in Vericel Corp stock. As of the latest transaction made, Ameritas Advisory Services, LLC holds 700 shares of VCEL stock, worth $23,513. This represents 0.0% of its overall portfolio holdings.

Number of Shares
700
Holding current value
$23,513
% of portfolio
0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Jul 21, 2025

BUY
$37.92 - $45.7 $26,544 - $31,990
700 New
700 $29,000
Q1 2023

Apr 28, 2023

BUY
$23.85 - $31.34 $33,747 - $44,346
1,415 New
1,415 $41,000

Others Institutions Holding VCEL

About Vericel Corp


  • Ticker VCEL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 47,178,000
  • Market Cap $1.58B
  • Description
  • Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States. The company markets autologous cell therapy products comprising MACI, an autologous cellularized scaffold product for t...
More about VCEL
Track This Portfolio

Track Ameritas Advisory Services, LLC Portfolio

Follow Ameritas Advisory Services, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ameritas Advisory Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ameritas Advisory Services, LLC with notifications on news.